Research suggests that GLP-1 medications, often used for weight loss, may also have a potential benefit in reducing the risk of breast cancer. Some studies have found a link between GLP-1 use and lower breast cancer incidence, although the extent of this benefit is still being explored. The relationship between GLP-1s and breast cancer risk is a topic of ongoing research, with some studies and experts weighing in on the potential implications for breast cancer patients and prevention.